Maplight Therapeutics, Inc. · NASDAQ:MPLT
T. Rowe Price Investment Management, Inc. reported a 7.40% stake in Maplight Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Investment Management, Inc. reported a 7.40% stake in Maplight Therapeutics, Inc., 3,137,558 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.40%
- Shares
- 3,137,558
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 7.40% | 3,137,558 |
Source
Related
- Maplight Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Maplight Therapeutics, Inc. shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Feb 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026